BTN2A1 and cancer: Recent findings indicated that Vγ9Vδ2 TCR senses the intracellular accumulation of phosphoantigen (pAg) bound with the BTN2A1/3A1 complex in cancer cells and activates the anti-tumor response of γδ2 T cells [27].